$IRAA
Iris Acquisition Corp Stock $iraa

$iraa Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000141057824000503 Filed on April 17, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$642.7K	$2.311M	$1.320M
YoY Change	-51.31%	23.59%	-8.97%
Operating Profit		-$2.311M
YoY Change		23.43%
Interest Expense	$46.23K	$103.1K	$2.870M
YoY Change	-98.39%	-96.64%	28600.0%
% of Operating Profit
Other Income/Expense, Net	$123.5K	$1.119M	-$1.170M
YoY Change	-110.55%	-91.16%	-200.0%
Pretax Income	-$473.0K	-$1.192M	$390.0K
YoY Change	-221.28%	-111.05%	-244.44%
Income Tax	$13.60K	$33.99K	$400.0K
% Of Pretax Income			102.56%
Net Earnings	-$486.6K	-$1.226M	-$10.00K
YoY Change	4766.0%	-111.96%	-96.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.07	-$0.15	$0.00
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$156.4K	$156.4K	$300.0K
YoY Change	-47.86%	-47.86%	0.0%
Cash & Equivalents	$156.4K		$280.6K
Short-Term Investments
Other Short-Term Assets	$0.00	$0.00	$100.0K
YoY Change	-100.0%	-100.0%	0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables	$1.256K		$1.256K
Total Short-Term Assets	$210.9K	$210.9K	$360.6K
YoY Change	-41.53%	-47.28%	-14.52%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$4.291M	$4.291M	$15.10M
YoY Change	-71.58%	-71.58%	-94.53%
Other Assets
YoY Change
Total Long-Term Assets	$4.291M	$4.291M	$15.13M
YoY Change	-71.63%	-71.58%	-94.52%
TOTAL ASSETS
Total Short-Term Assets	$210.9K	$210.9K	$360.6K
Total Long-Term Assets	$4.291M	$4.291M	$15.13M
Total Assets	$4.502M	$4.502M	$15.49M
YoY Change	-70.93%	-70.95%	-94.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.997M	$1.997M	$1.500M
YoY Change	33.13%	33.13%	36.36%
Accrued Expenses	$103.6K	$433.6K	$400.0K
YoY Change	-74.1%	8.4%	100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$2.271M	$2.271M	$1.000M
YoY Change	127.09%	127.09%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.159M	$5.159M	$3.591M
YoY Change	43.64%	43.29%	160.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$10.04M	$10.04M	$10.60M
YoY Change	-5.32%	-5.32%	-47.52%
Total Long-Term Liabilities	$10.04M	$10.04M	$10.60M
YoY Change	-5.32%	-5.32%	-47.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.159M	$5.159M	$3.591M
Total Long-Term Liabilities	$10.04M	$10.04M	$10.60M
Total Liabilities	$15.19M	$15.20M	$14.19M
YoY Change	7.05%	7.01%	-34.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.88M		-$13.97M
YoY Change	6.51%		-33.87%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$14.74M	-$10.69M	-$13.83M
YoY Change
Total Liabilities & Shareholders Equity	$4.502M	$4.502M	$15.49M
YoY Change	-70.93%	-70.95%	-94.4%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	-$486.6K	-$1.226M	-$10.00K
YoY Change	4766.0%	-111.96%	-96.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$627.1K	-$2.089M	-$50.00K
YoY Change	1154.2%	90.69%	-80.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$42.70K	$11.39M	$264.0M
YoY Change	-100.02%	-95.68%
Cash From Investing Activities	-$42.70K	$11.39M	$264.0M
YoY Change	-100.02%	-95.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	488.5K	-9.425M	-263.8M
YoY Change	-100.19%	-96.42%
NET CHANGE
Cash From Operating Activities	-627.1K	-2.089M	-50.00K
Cash From Investing Activities	-42.70K	11.39M	264.0M
Cash From Financing Activities	488.5K	-9.425M	-263.8M
Net Change In Cash	-181.3K	-124.2K	150.0K
YoY Change	-220.87%	123.46%	-160.0%
FREE CASH FLOW
Cash From Operating Activities	-$627.1K	-$2.089M	-$50.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001831874
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	iraa	Redemption Of Shares Calculated Based On Number Of Business Days Prior To Consummation Of Business Combination RedemptionOfSharesCalculatedBasedOnNumberOfBusinessDaysPriorToConsummationOfBusinessCombination	P2D
CY2021Q1	iraa	Number Of Warrants Issued Per Unit NumberOfWarrantsIssuedPerUnit	0.25
CY2021Q1	iraa	Redemption Period RedemptionPeriod	P30D
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet
CY2022	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.tribecapitalgrowthcorp.com/20231231#UnrealizedGainLossOnChangeInFairValueOfWarrantLiabilities
CY2023	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://www.tribecapitalgrowthcorp.com/20231231#UnrealizedGainLossOnChangeInFairValueOfWarrantLiabilities
CY2021Q1	iraa	Threshold Business Days For Redemption Of Public Shares ThresholdBusinessDaysForRedemptionOfPublicShares	P10D
CY2023	dei	Entity Registrant Name EntityRegistrantName	Iris Acquisition Corp
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40167
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3901431
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3rd Floor Zephyr House
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	122 Mary Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	George Town
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10085
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Grand Cayman KY1-1001
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	KY
CY2023	dei	City Area Code CityAreaCode	971
CY2023	dei	Local Phone Number LocalPhoneNumber	4 3966949
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	14823461
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum llp
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash Cash	156425
CY2022Q4	us-gaap	Cash Cash	280640
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1256
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1256
CY2023Q4	iraa	Franchise Tax Receivable Current FranchiseTaxReceivableCurrent	53200
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	78753
CY2023Q4	us-gaap	Assets Current AssetsCurrent	210881
CY2022Q4	us-gaap	Assets Current AssetsCurrent	360649
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	4291332
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	15127621
CY2023Q4	us-gaap	Assets Assets	4502213
CY2022Q4	us-gaap	Assets Assets	15488270
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2326918
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1489462
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	75000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	75000
CY2022Q4	iraa	Franchise Tax Payable FranchiseTaxPayable	447133
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	379965
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	539823
CY2023Q4	iraa	Excise Tax Payable Current ExciseTaxPayableCurrent	103587
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2202
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5158553
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3591418
CY2023Q4	iraa	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	9660000
CY2022Q4	iraa	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	9660000
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	376444
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	942646
CY2023Q4	us-gaap	Liabilities Liabilities	15194997
CY2022Q4	us-gaap	Liabilities Liabilities	14194064
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	140000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	140000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14883124
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13974105
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-14742434
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-13833415
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4502213
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15488270
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	85084
CY2023	iraa	Operating Bank Accounts OperatingBankAccounts	156425
CY2023	iraa	Formation And Operating Costs FormationAndOperatingCosts	2586211
CY2022	iraa	Formation And Operating Costs FormationAndOperatingCosts	2452467
CY2023	iraa	Forgiveness Of Unrelated Vendor Payable ForgivenessOfUnrelatedVendorPayable	275000
CY2022	iraa	Forgiveness Of Unrelated Vendor Payable ForgivenessOfUnrelatedVendorPayable	579989
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2311211
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1872478
CY2023	iraa	Unrealized Gain Loss On Change In Fair Value Of Warrant Liabilities UnrealizedGainLossOnChangeInFairValueOfWarrantLiabilities	566202
CY2022	iraa	Unrealized Gain Loss On Change In Fair Value Of Warrant Liabilities UnrealizedGainLossOnChangeInFairValueOfWarrantLiabilities	9586864
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	102226
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	553641
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3074691
CY2023	us-gaap	Interest Expense InterestExpense	103089
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1118980
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12661555
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1192231
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10789077
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33987
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	539823
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1226218
CY2022	us-gaap	Net Income Loss NetIncomeLoss	10249254
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-21131135
CY2022	iraa	Adjustments To Additional Paid In Capital Forgiveness Of Payable Due To Affiliate Of Sponsor AdjustmentsToAdditionalPaidInCapitalForgivenessOfPayableDueToAffiliateOfSponsor	140000
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3091534
CY2022	us-gaap	Net Income Loss NetIncomeLoss	10249254
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-13833415
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	420786
CY2023	iraa	Excise Tax Payable Attributable Toredemption Of Common Stock ExciseTaxPayableAttributableToredemptionOfCommonStock	103587
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1226218
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-14742434
CY2023	us-gaap	Profit Loss ProfitLoss	-1226218
CY2022	us-gaap	Profit Loss ProfitLoss	10249254
CY2023	iraa	Unrealized Gain Loss On Change In Fair Value Of Warrant Liabilities UnrealizedGainLossOnChangeInFairValueOfWarrantLiabilities	566202
CY2022	iraa	Unrealized Gain Loss On Change In Fair Value Of Warrant Liabilities UnrealizedGainLossOnChangeInFairValueOfWarrantLiabilities	9586864
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	102226
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	103089
CY2023	iraa	Forgiveness Of Unrelated Vendor Payable ForgivenessOfUnrelatedVendorPayable	275000
CY2022	iraa	Forgiveness Of Unrelated Vendor Payable ForgivenessOfUnrelatedVendorPayable	579989
CY2023	iraa	Interest Earned On Cash And Investments Held In Trust Accounts InterestEarnedOnCashAndInvestmentsHeldInTrustAccounts	553641
CY2022	iraa	Interest Earned On Cash And Investments Held In Trust Accounts InterestEarnedOnCashAndInvestmentsHeldInTrustAccounts	3074691
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-78753
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-5685
CY2023	iraa	Increase Decrease In Franchise Tax Receivable IncreaseDecreaseInFranchiseTaxReceivable	53200
CY2023	iraa	Increase Decrease Franchise Tax Payable IncreaseDecreaseFranchiseTaxPayable	-447133
CY2022	iraa	Increase Decrease Franchise Tax Payable IncreaseDecreaseFranchiseTaxPayable	247133
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-159858
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	539823
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	125000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1112456
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	979061
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2089180
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1095588
CY2022	iraa	Payments To Vendors In Cash As Settlement Of Forgiveness PaymentsToVendorsInCashAsSettlementOfForgiveness	250000
CY2023	iraa	Proceeds From Trust Accounts For Redemptions ProceedsFromTrustAccountsForRedemptions	10657185
CY2022	iraa	Proceeds From Trust Accounts For Redemptions ProceedsFromTrustAccountsForRedemptions	279091534
CY2023	iraa	Proceeds From Trust Accounts For Tax Payments ProceedsFromTrustAccountsForTaxPayments	853261
CY2023	iraa	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	120516
CY2022	iraa	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	15127621
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11389930
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	263963913
CY2023	iraa	Accretion Of Common Stock Subject To Redemption Value AccretionOfCommonStockSubjectToRedemptionValue	10657185
CY2022	iraa	Accretion Of Common Stock Subject To Redemption Value AccretionOfCommonStockSubjectToRedemptionValue	263963913
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	400000
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	400000
CY2023	iraa	Repayment Of Related Party Promissory Notes RepaymentOfRelatedPartyPromissoryNotes	120000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9424965
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-262923913
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-124215
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-55588
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280640
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	336228
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	156425
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280640
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	193845
CY2023	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	103587
CY2023	iraa	Conversion Of Common Stock From One Class To Another Class ConversionOfCommonStockFromOneClassToAnotherClass	690
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	420786
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3091534
CY2023	iraa	Derivative On Promissory Note Related Party DerivativeOnPromissoryNoteRelatedParty	104428
CY2022	iraa	Forgiveness Of Payable Due To Affiliate Of Sponsor Included In Due To Related Party ForgivenessOfPayableDueToAffiliateOfSponsorIncludedInDueToRelatedParty	140000
CY2021Q1	iraa	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1
CY2021Q1	iraa	Minimum Net Tangible Assets Upon Consummation Of Business Combination MinimumNetTangibleAssetsUponConsummationOfBusinessCombination	5000001
CY2021Q1	iraa	Maximum Net Interest To Pay Dissolution Expenses MaximumNetInterestToPayDissolutionExpenses	100000
CY2023	iraa	Operating Bank Accounts OperatingBankAccounts	156425
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	85084
CY2023Q4	iraa	Working Capital WorkingCapital	4947672
CY2022Q4	iraa	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	0
CY2023Q4	iraa	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	0
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. The Class A ordinary shares subject to possible redemption and the valuation of the Private Placement Warrants required management to exercise significant judgement in its estimates.</p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	156425
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	280640
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	85084
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	4291332
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	15127621
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. As of December 31, 2023 and 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">On May 1, 2023, JPMorgan Chase & Co. acquired all deposit accounts and substantially all the assets and assumed certain of the liabilities of First Republic Bank (“FRB”) following a seizure by the U.S. Federal Deposit Insurance Corporation. The Company maintained cash deposits with FRB. The Company experienced no material impact on its financial statements or day-to-day operations as a result of these developments.</p>
CY2023	iraa	Forgiveness Of Outstanding Vendor Payable ForgivenessOfOutstandingVendorPayable	350000
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	75000
CY2022	iraa	Forgiveness Of Outstanding Vendor Payable ForgivenessOfOutstandingVendorPayable	829989
CY2023	iraa	Forgiveness Of Unrelated Vendor Payable ForgivenessOfUnrelatedVendorPayable	275000
CY2022	iraa	Forgiveness Of Unrelated Vendor Payable ForgivenessOfUnrelatedVendorPayable	579989
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	9.96
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.71
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11913333
CY2023	us-gaap	Interest Expense InterestExpense	103089
CY2022	us-gaap	Interest Expense InterestExpense	0
CY2023	iraa	Debt Embedded Derivative Redemption Feature Percentage Of Principal Amount DebtEmbeddedDerivativeRedemptionFeaturePercentageOfPrincipalAmount	1.50
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	103587
CY2023	iraa	Percentage Of Excise Tax Calculated On Fair Market Value Of Shares Redeemed PercentageOfExciseTaxCalculatedOnFairMarketValueOfSharesRedeemed	0.01
CY2023	iraa	Schedule Of Common Stock Reflected On Balance Sheet Are Reconciled ScheduleOfCommonStockReflectedOnBalanceSheetAreReconciled	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:81.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:81.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Class A common stock subject to possible redemption at January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 276,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Plus: Remeasurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,091,534</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: Shares redeemed in December 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (263,963,913)</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Class A common stock subject to possible redemption at December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,127,621</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: Remeasurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (420,786)</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: 2023 adjustment to share price for shares redeemed in December 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (298,431)</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: Shares redeemed in September 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(10,358,754)</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Class A common stock subject to possible redemption at December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,049,650</p></td></tr></table>
CY2021Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1996912
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	594958
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	45400
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	826134
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	284606
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	68370
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2326918
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1489462
CY2023Q4	us-gaap	Notes Payable NotesPayable	1452381
CY2022Q4	us-gaap	Notes Payable NotesPayable	1040000
CY2023Q4	iraa	Maximum Number Of Demands For Registration Of Securities MaximumNumberOfDemandsForRegistrationOfSecurities	3
CY2023	iraa	Underwriting Discount As Percentage Of Gross Proceeds From Initial Public Offering UnderwritingDiscountAsPercentageOfGrossProceedsFromInitialPublicOffering	0.02
CY2023Q4	iraa	Underwriting Costs Noncurrent UnderwritingCostsNoncurrent	5520000
CY2023	iraa	Deferred Underwriting Discount As Percentage Of Gross Proceeds From Initial Public Offering DeferredUnderwritingDiscountAsPercentageOfGrossProceedsFromInitialPublicOffering	0.035
CY2023Q4	iraa	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	9660000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	iraa	Common Stock Number Of Votes Per Share CommonStockNumberOfVotesPerShare	1
CY2023Q4	iraa	Deferred Tax Assets Capitalized Start Up And Organization Costs DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts	1041535
CY2022Q4	iraa	Deferred Tax Assets Capitalized Start Up And Organization Costs DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts	637807
CY2023Q4	iraa	Deferred Tax Assets Accrued Interest DeferredTaxAssetsAccruedInterest	7307
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1048842
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	637807
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1048842
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	637807
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	33987
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	539823
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-411035
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-287359
CY2023	iraa	Increase Decrease In Valuation Allowance IncreaseDecreaseInValuationAllowance	411035
CY2022	iraa	Increase Decrease In Valuation Allowance IncreaseDecreaseInValuationAllowance	287359
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33987
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	539823
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	411035
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	287359
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2023	iraa	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants Liability Percent EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantsLiabilityPercent	0.0998
CY2022	iraa	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants Liability Percent EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantsLiabilityPercent	-0.1866
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.2083
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0062
CY2023	iraa	Effective Income Tax Rate Reconciliation Acquisitions Facilitative Expenses Percent EffectiveIncomeTaxRateReconciliationAcquisitionsFacilitativeExpensesPercent	-0.1954
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3450
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0266
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0285
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0500
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	376444
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	942646
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001410578-24-000503-index-headers.html	Edgar Link	pending
0001410578-24-000503-index.html	Edgar Link	pending
0001410578-24-000503.txt	Edgar Link	pending
0001410578-24-000503-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iraa-20231231.xsd	Edgar Link	pending
iraa-20231231x10k.htm	Edgar Link	pending
iraa-20231231xex10d14.htm	Edgar Link	pending
iraa-20231231xex10d15.htm	Edgar Link	pending
iraa-20231231xex10d19.htm	Edgar Link	pending
iraa-20231231xex10d20.htm	Edgar Link	pending
iraa-20231231xex2d3.htm	Edgar Link	pending
iraa-20231231xex2d4.htm	Edgar Link	pending
iraa-20231231xex31d1.htm	Edgar Link	pending
iraa-20231231xex31d2.htm	Edgar Link	pending
iraa-20231231xex32d1.htm	Edgar Link	pending
iraa-20231231xex32d2.htm	Edgar Link	pending
iraa-20231231xex97.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
iraa-20231231_cal.xml	Edgar Link	unprocessable
iraa-20231231_def.xml	Edgar Link	unprocessable
iraa-20231231_lab.xml	Edgar Link	unprocessable
iraa-20231231_pre.xml	Edgar Link	unprocessable
iraa-20231231x10k_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IRAA
Iris Acquisition Corp Stock $iraa

2023 Q4 Form 10-K Financial Statement

#000141057824000503 Filed on April 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRAA Iris Acquisition Corp Stock $iraa

2023 Q4 Form 10-K Financial Statement

#000141057824000503 Filed on April 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRAA
Iris Acquisition Corp Stock $iraa